158 related articles for article (PubMed ID: 28757276)
1. Value of immunohistochemical expression of podocalyxin in active lupus nephritis.
Behairy MA; Shakweer MM; El Said TW; ElGharbawy NH
Nefrologia (Engl Ed); 2018; 38(1):64-72. PubMed ID: 28757276
[TBL] [Abstract][Full Text] [Related]
2. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
3. Urinary podocalyxin: Is it a real index of disease activity in egyptian patients lupus nephritis?
Fayed A; Elnokeety MM; Elyamny M; Hammad H; Soliman DHA; Ahmed RA
Saudi J Kidney Dis Transpl; 2020; 31(6):1198-1205. PubMed ID: 33565431
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
5. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
6. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
Fu R; Guo C; Wang S; Huang Y; Jin O; Hu H; Chen J; Xu B; Zhou M; Zhao J; Sung SJ; Wang H; Gaskin F; Yang N; Fu SM
Arthritis Rheumatol; 2017 Aug; 69(8):1636-1646. PubMed ID: 28544564
[TBL] [Abstract][Full Text] [Related]
7. Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.
Lu J; Hu ZB; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ma KL
BMC Nephrol; 2019 Aug; 20(1):303. PubMed ID: 31382919
[TBL] [Abstract][Full Text] [Related]
8. The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.
Ikuma D; Hiromura K; Kajiyama H; Suwa J; Ikeuchi H; Sakairi T; Kaneko Y; Maeshima A; Kurosawa H; Hirayama Y; Yokota K; Araki Y; Sato K; Asanuma YF; Akiyama Y; Hara M; Nojima Y; Mimura T
Lupus; 2018 Mar; 27(3):484-493. PubMed ID: 29050536
[TBL] [Abstract][Full Text] [Related]
9. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
11. Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis.
Moustafa FE; Soliman NA; Bakr AM; El Shwaf IM
Lupus; 2014 Feb; 23(2):146-50. PubMed ID: 24306541
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
[TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
15. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
[TBL] [Abstract][Full Text] [Related]
16. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
[TBL] [Abstract][Full Text] [Related]
17. Expression of podocyte-associated molecules in acquired human kidney diseases.
Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
19. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.
Wada Y; Iyoda M; Suzuki T; Tachibana S; Kanazawa N; Matsumoto K; Honda H
Virchows Arch; 2021 Nov; 479(5):997-1005. PubMed ID: 34302213
[TBL] [Abstract][Full Text] [Related]
20. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
